NEW YORK (GenomeWeb News) — PolyOrg said today that it has licensed from the Copenhagen Inventor Group the right to make and sell PNA monomers worldwide.

PNAs are oligonucleotide analogs in which the sugar-phosphate backbone of DNA is substituted by amino-ethyl-glycine backbone. They hybridize strongly to complementary DNA or RNA but are not degraded by nucleases or proteases, the company said, and they are useful for molecular biology and diagnostics applications and antisense and anti-gene therapies.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

A new analysis examines the gender gap among paper authors in the sciences and says it may take decades or more to close.

Researchers have uncovered signals of selection that may enable the Bajau people to free five hundreds of feet deep, Reuters reports.

In Science this week: paternally inherited cis-regulatory structural variants in autism, and more.

A new report outlines issues facing the implementation of personalized medicine in the UK, the Independent reports.